GO:0003190 atrioventricular valve formation: Developmental Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003190 (atrioventricular valve formation) describes the initial developmental process that builds the atrioventricular (AV) valve from unspecified parts, ending when the structural rudiment becomes recognizable.
• The process depends on endocardial-to-mesenchymal transition (EndoMT), endocardial cushion formation, and subsequent remodeling into thin, mobile leaflets.
• Key transcription factors such as Tbx2 and Tbx3 pattern the AV myocardium and induce cushion formation, while TGF-beta signaling drives endocardial cell transformation.
• Mechanosensitive and calcium-permeable channels, including multiple pkd and piezo family members, are required for normal AV valve formation in vivo.
• Disruption of AV valve formation causes congenital heart defects such as atrioventricular septal defects and valve stenosis, and is linked to endomyocardial fibrosis.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in AV valve development.
Description
Atrioventricular valve formation (GO:0003190) is the developmental process that initially builds the atrioventricular (AV) valve from unspecified parts, beginning with the specific processes that contribute to the appearance of the discrete structure and ending when the structural rudiment is recognizable. This term captures the earliest morphogenetic events that establish the AV valve, a critical structure that ensures unidirectional blood flow between the atria and ventricles. Defects in this process are a major cause of congenital heart disease and contribute to significant morbidity and mortality. Understanding the molecular and cellular mechanisms of AV valve formation is therefore essential for developmental biologists, cardiologists, and researchers modeling human heart disease. The AV valve forms through a coordinated series of events, including endocardial cushion formation, endothelial-to-mesenchymal transition (EndoMT), and subsequent remodeling of the cushion into thin, mobile leaflets. These events are regulated by signaling pathways such as TGF-beta, which stimulates endocardial cell transformation through Par6c-dependent regulation of RhoA. Transcription factors like Tbx2 and Tbx3 pattern the AV myocardium and induce cushion formation, while mechanosensitive channels such as pkd and piezo family members transduce biomechanical forces essential for leaflet morphogenesis. Disruption of any of these steps can lead to AV valve malformations, including atrioventricular septal defects and valve stenosis. Research on AV valve formation has been accelerated by advances in genetic models, imaging, and CRISPR-based genome editing. Zebrafish and mouse models have been particularly valuable for dissecting the genetic and biomechanical control of AV valve development. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0003190, covering its definition, mechanisms, key genes, disease links, and experimental methods.
atrioventricular valve formation At A Glance
| GO ID | GO:0003190 |
|---|---|
| GO term | atrioventricular valve formation |
| Ontology | biological_process |
| Synonym | AV valve formation |
| Major function | Initial formation of the atrioventricular valve from unspecified parts, ending when the structural rudiment is recognizable |
| Key cellular process | Endocardial cushion formation and endothelial-to-mesenchymal transition (EndoMT) |
| Key signaling pathways | TGF-beta signaling, Par6c/RhoA regulation, and mechanotransduction via pkd/piezo channels |
| Key transcription factors | Tbx2 and Tbx3 |
| Associated diseases | Congenital heart defects, atrioventricular septal defects, endomyocardial fibrosis |
What Is GO:0003190?
GO:0003190 (atrioventricular valve formation) is defined as the developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. In other words, it covers the earliest steps that build the AV valve, from the initiation of cushion formation to the point where a recognizable valve rudiment exists, but not the later maturation or remodeling stages.
Why Is atrioventricular valve formation Important in Cell Biology?
Atrioventricular valve formation is essential for establishing unidirectional blood flow in the developing heart, and its disruption leads to congenital heart defects that require lifelong management. The process integrates genetic, signaling, and biomechanical inputs, making it a paradigm for studying how mechanical forces shape organ morphogenesis. Because AV valve malformations are among the most common congenital heart anomalies, understanding the molecular mechanisms of GO:0003190 is critical for developing diagnostic and therapeutic strategies. Moreover, the genes and pathways involved, such as TGF-beta signaling and Tbx2/Tbx3, are conserved across vertebrates, enabling the use of model organisms for mechanistic studies.
• AV valve formation is a critical step in heart development; failure causes congenital heart defects such as atrioventricular septal defects.
• The process involves endocardial cushion formation and EndoMT, which are paradigms for studying cell fate transitions.
• TGF-beta signaling through Par6c and RhoA is required for endocardial cell transformation during cushion formation.
• Tbx2 and Tbx3 are key transcription factors that pattern the AV myocardium and induce cushion formation.
• Mechanosensitive pkd and piezo channels are required for AV valve formation, linking biomechanics to gene regulation.
• Disruption of AV valve formation is associated with endomyocardial fibrosis, a restrictive cardiomyopathy.
• Zebrafish models have revealed that environmental toxicants such as butylparaben can impair AV valve formation via oxidative stress.
• Understanding AV valve formation informs tissue engineering and regenerative strategies for valve replacement.
• CRISPR-based editing enables precise testing of candidate genes in AV valve development.
• The process is conserved across vertebrates, allowing translation of findings from fish and mouse models to humans.
What Happens During atrioventricular valve formation?
Endocardial cushion formation
In simple terms: The heart tube develops bulges of tissue called cushions that will become the valve leaflets.
The first morphological sign of AV valve formation is the appearance of endocardial cushions, which are swellings of extracellular matrix between the myocardium and endocardium in the AV canal. These cushions form in response to signals from the AV myocardium, including Tbx2 and Tbx3, which induce cushion formation and pattern the AV canal. The cushions serve as the primordia for the valve leaflets and septa. Disruption of cushion formation leads to AV septal defects.
Endothelial-to-mesenchymal transition (EndoMT)
In simple terms: Cells lining the heart tube change into migratory cells that populate the cushions.
Endocardial cells overlying the cushions undergo EndoMT, a process in which they lose endothelial markers, gain mesenchymal properties, and invade the cushion matrix. This transition is driven by TGF-beta signaling, which activates Par6c and RhoA to promote endocardial cell transformation. EndoMT is essential for cushion cellularization and subsequent valve morphogenesis. Defects in EndoMT result in hypocellular cushions and valve malformations.
Biomechanical forces and mechanotransduction
In simple terms: The flow of blood and physical forces help shape the valve leaflets.
Biomechanical forces generated by blood flow and heart contraction are critical for AV valve formation. Mechanosensitive channels, including multiple pkd and piezo family members, are required for AV valve formation in vivo, likely by transducing mechanical stimuli into cellular responses. These forces influence EndoMT, cell migration, and extracellular matrix remodeling. Perturbation of mechanotransduction leads to valve defects.
Remodeling into valve rudiment
In simple terms: The cushions are sculpted into thin, mobile leaflets.
After cushion formation and cellularization, the cushions undergo remodeling to form the primitive valve leaflets. This involves coordinated changes in cell shape, extracellular matrix composition, and apoptosis. The process ends when the structural rudiment of the AV valve is recognizable, as defined by GO:0003190. Remodeling is regulated by signaling pathways including TGF-beta and potentially by hemodynamic forces.
Key Genes Involved in GO:0003190 atrioventricular valve formation
The following genes and proteins have been experimentally implicated in atrioventricular valve formation (GO:0003190) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Tbx2 | Patterns AV myocardium and induces endocardial cushion formation | Transcription factor; knockout causes cushion defects |
| Tbx3 | Cooperates with Tbx2 in AV myocardial development and cushion formation | Transcription factor; implicated in AV valve development |
| TGF-beta | Stimulates endocardial cell transformation during EndoMT | Signaling ligand; key driver of cushion cellularization |
| Par6c | Regulates RhoA downstream of TGF-beta to promote EndoMT | Polarity protein; required for endocardial transformation |
| RhoA | Small GTPase regulated by Par6c; mediates TGF-beta-induced EndoMT | Signaling node; potential therapeutic target |
| Pkd1 | Mechanosensitive channel; required for AV valve formation | Polycystin; links biomechanics to valve morphogenesis |
| Pkd2 | Mechanosensitive channel; required for AV valve formation | Polycystin; mutations cause valve defects |
| Piezo1 | Mechanosensitive ion channel; required for AV valve formation | Mechanotransducer; potential role in valve disease |
| Piezo2 | Mechanosensitive ion channel; required for AV valve formation | Mechanotransducer; potential role in valve disease |
| Nkx2-5 | Early cardiac transcription factor; upstream of AV valve development | Marker of cardiac progenitors; mutations cause CHD |
| Gata4 | Cardiac transcription factor; involved in AV valve formation | Mutations associated with AV septal defects |
| Tbx5 | Cardiac transcription factor; implicated in AV valve development | Mutations cause Holt-Oram syndrome with AV defects |
| Bmp2 | Signaling ligand; promotes EndoMT and cushion formation | TGF-beta family member; key for cushion development |
| Bmp4 | Signaling ligand; involved in AV cushion formation | TGF-beta family member; regulates EndoMT |
| Notch1 | Signaling receptor; regulates EndoMT and valve development | Mutations linked to valve disease |
| Vegf | Signaling ligand; modulates EndoMT and cushion vascularization | Angiogenic factor; affects valve morphogenesis |
| Wnt/beta-catenin | Signaling pathway; regulates EndoMT and cushion formation | Developmental pathway; potential target |
| Sox9 | Transcription factor; involved in valve progenitor differentiation | Chondrogenic factor; role in cushion mesenchyme |
How Is atrioventricular valve formation Regulated?
Atrioventricular valve formation is regulated by a complex interplay of signaling pathways and transcription factors. TGF-beta signaling, acting through Par6c and RhoA, is a central regulator of EndoMT and cushion cellularization. Tbx2 and Tbx3 act as transcriptional regulators that pattern the AV myocardium and induce cushion formation. Biomechanical forces transduced by mechanosensitive channels such as pkd and piezo family members modulate EndoMT and remodeling. Additionally, environmental factors such as oxidative stress and immunosuppression can impair AV valve formation, as shown in zebrafish exposed to butylparaben. These regulatory inputs ensure the precise spatiotemporal control of AV valve morphogenesis.
atrioventricular valve formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Tbx2 | Congenital heart defects; AV cushion malformation | Tbx2 knockout mouse; zebrafish tbx2 morphant |
| Tbx3 | AV valve defects; conduction system abnormalities | Tbx3 conditional knockout mouse |
| TGF-beta/Par6c/RhoA | EndoMT failure; hypocellular cushions | Par6c or RhoA knockout mouse; cell culture EndoMT assays |
| Pkd1/Pkd2 | Valve defects; mechanotransduction failure | Zebrafish pkd mutants; mouse Pkd1 conditional knockout |
| Piezo1/Piezo2 | AV valve malformation; mechanosensing defects | Zebrafish piezo mutants; mouse Piezo1 knockout |
Congenital heart defects
Disruption of atrioventricular valve formation causes congenital heart defects, including atrioventricular septal defects and valve stenosis. Mutations in cardiac transcription factors such as Nkx2-5, Gata4, and Tbx5 are associated with AV valve malformations in humans. Animal models with targeted deletions of Tbx2, Tbx3, or TGF-beta signaling components exhibit cushion and valve defects, confirming the importance of these genes in disease.
Endomyocardial fibrosis
Endomyocardial fibrosis is a restrictive cardiomyopathy characterized by fibrous thickening of the endocardium, often involving the AV valves. Although the etiology is multifactorial, impaired AV valve development and subsequent remodeling may contribute to valve dysfunction in this disease. The condition is prevalent in tropical regions and carries high morbidity.
Environmental and toxicant-induced valve defects
Exposure to environmental toxicants such as butylparaben can induce systolic heart failure in zebrafish through oxidative stress and immunosuppression, with associated defects in AV valve formation. This highlights the sensitivity of AV valve development to environmental insults and the utility of zebrafish as a model for toxicological studies.
From atrioventricular valve formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for AV valve formation? | Knockout (e.g., CRISPR-Cas9) in zebrafish or mouse |
| Does a specific point mutation in gene X cause valve defects? | Point-mutation knock-in via CRISPR in zebrafish or mouse |
| What is the spatiotemporal expression of gene X during AV valve formation? | Tagged knock-in (e.g., GFP) or reporter line |
| Does overexpression of gene X drive EndoMT or cushion formation? | Overexpression via transgenic or viral vectors in zebrafish or mouse |
| How do biomechanical forces regulate gene X during valve formation? | Zebrafish with altered flow; mechanosensitive channel mutants |
| What is the role of gene X in human AV valve development? | Human induced pluripotent stem cell-derived endocardial cells |
How to Study the atrioventricular valve formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live imaging (zebrafish/mouse) | Cell movements and morphogenesis during cushion formation | Tracking EndoMT and valve remodeling |
| Single-cell RNA-seq | Transcriptional heterogeneity of endocardial/mesenchymal cells | Identifying novel regulators of AV valve formation |
| CRISPR knockout | Gene function by loss-of-function | Testing candidate genes in zebrafish/mouse |
| CRISPR knock-in (point mutation) | Effect of specific variants | Modeling human disease variants |
| Immunohistochemistry | Protein localization and expression | Validating gene expression in AV cushions |
| Calcium imaging | Activity of mechanosensitive channels | Assessing Piezo/Pkd function |
| Microfluidics | Shear stress effects on endocardial cells | Studying biomechanics of valve formation |
| Tissue clearing and 3D imaging | 3D architecture of developing AV valve | Visualizing valve rudiment formation |
Genetic lineage tracing and imaging
Lineage tracing using Cre-lox or fluorescent reporters allows visualization of endocardial and mesenchymal cell contributions to AV valve formation. Live imaging in zebrafish and mouse enables dynamic tracking of cushion formation and EndoMT. These methods are essential for understanding cell behaviors during valve morphogenesis.
Transcriptomics and single-cell RNA sequencing
RNA sequencing of microdissected AV canals or sorted endocardial cells can identify genes and pathways differentially expressed during AV valve formation. Single-cell RNA-seq reveals heterogeneity among endocardial and mesenchymal populations. These approaches have implicated TGF-beta, Notch, and Wnt signaling in EndoMT.
Biomechanical and mechanotransduction assays
Microfluidic devices and zebrafish models with altered blood flow are used to study how mechanical forces influence AV valve formation. Calcium imaging and patch-clamp electrophysiology can assess the activity of mechanosensitive channels such as Piezo and Pkd. These methods link physical forces to cellular responses.
CRISPR-based functional genomics
CRISPR-Cas9 knockout and knock-in in zebrafish and mouse enable rapid testing of candidate genes for roles in AV valve formation. Pooled CRISPR screens can identify novel regulators of EndoMT and cushion formation. These approaches are powerful for causal gene discovery.
How CRISPR Can Be Used to Study GO:0003190 atrioventricular valve formation
Knockout
CRISPR-Cas9 knockout of candidate genes in zebrafish or mouse is used to test their requirement for AV valve formation. For example, knockout of pkd or piezo family members in zebrafish results in AV valve defects, demonstrating their essential roles. Knockout models allow assessment of loss-of-function phenotypes in a whole-animal context.
Point Mutation
CRISPR-mediated point mutations can model human variants associated with congenital heart defects. By introducing specific amino acid substitutions in genes such as Tbx2 or Tbx3, researchers can dissect the functional impact of disease-associated alleles. Point-mutation knock-in models are valuable for understanding genotype-phenotype relationships.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows visualization and biochemical analysis of proteins during AV valve formation. Tagged knock-in models can reveal spatiotemporal expression patterns and protein interactions. This approach is particularly useful for low-abundance regulatory proteins.
Overexpression
Overexpression of candidate genes via transgenic or viral delivery can test sufficiency for driving EndoMT or cushion formation. For instance, overexpression of TGF-beta or Bmp2 in the AV canal may enhance EndoMT. Overexpression models complement loss-of-function studies to establish causality.
How EDITGENE Supports atrioventricular valve formation Research
Researchers studying atrioventricular valve formation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. This requires precise genetic manipulation in model systems, which is where EDITGENE's CRISPR services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for atrioventricular valve formation research.
Frequently Asked Questions About atrioventricular valve formation
What is atrioventricular valve formation (GO:0003190)?
It is the developmental process that initially forms the atrioventricular valve from unspecified parts, beginning with the appearance of the discrete structure and ending when the structural rudiment is recognizable.
What genes are involved in atrioventricular valve formation?
Key genes include Tbx2, Tbx3, TGF-beta signaling components (Par6c, RhoA), and mechanosensitive channels such as Pkd1, Pkd2, Piezo1, and Piezo2.
What is the role of EndoMT in AV valve formation?
Endothelial-to-mesenchymal transition (EndoMT) is the process by which endocardial cells transform into mesenchymal cells that populate the endocardial cushions, a critical step for valve formation.
How does TGF-beta signaling regulate AV valve formation?
TGF-beta stimulates endocardial cell transformation through Par6c-dependent regulation of RhoA, driving EndoMT and cushion cellularization.
What diseases are associated with defective atrioventricular valve formation?
Defects cause congenital heart defects such as atrioventricular septal defects and valve stenosis, and are linked to endomyocardial fibrosis.
What model organisms are used to study AV valve formation?
Zebrafish and mouse are the primary models, offering genetic tractability and conserved developmental mechanisms.
How do mechanosensitive channels contribute to AV valve formation?
Pkd and Piezo family channels transduce biomechanical forces into cellular signals required for EndoMT and valve remodeling.
What is the role of Tbx2 and Tbx3 in AV valve formation?
Tbx2 and Tbx3 pattern the AV myocardium and induce endocardial cushion formation, acting as key transcriptional regulators.
Can CRISPR be used to study AV valve formation?
Yes, CRISPR-Cas9 knockout, point-mutation knock-in, and overexpression in zebrafish and mouse enable causal testing of candidate genes.
What methods are used to study AV valve formation?
Common methods include live imaging, single-cell RNA-seq, CRISPR screens, immunohistochemistry, and biomechanical assays.
Conclusion
Atrioventricular valve formation (GO:0003190) is a fundamental developmental process that integrates genetic, signaling, and biomechanical inputs to build the AV valve rudiment. Key genes such as Tbx2, Tbx3, and components of TGF-beta signaling, as well as mechanosensitive channels, have been shown to be essential. Disruption of this process leads to congenital heart defects and other cardiac pathologies, underscoring its clinical relevance. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate the mechanisms of AV valve formation and inform therapeutic strategies.
References
- 1. Joziasse IC et al.. 2008. Genes in congenital heart disease: atrioventricular valve formation.. Basic Res Cardiol 103(3):216-27 PMID: 18392768
- 2. Yang A et al.. 2026. Making Mobile Leaflets: Biomechanical Forces in Atrioventricular Valve Formation.. Cells 15(6) PMID: 41892351
- 3. Wang J et al.. 2026. The regulation of endothelial-to-mesenchymal transition in endocardial cushion development: Signaling pathways and transcription factors.. Differentiation 151:100987 PMID: 42600378
- 4. Iroegbu CD et al.. 2020. Endomyocardial fibrosis.. Cardiovasc Diagn Ther 10(2):208-222 PMID: 32420101
- 5. Zhu H et al.. 2023. Systolic heart failure induced by butylparaben in zebrafish is caused through oxidative stress and immunosuppression.. Ecotoxicol Environ Saf 268:115692 PMID: 37981439
- 6. Juan T et al.. 2023. Multiple pkd and piezo gene family members are required for atrioventricular valve formation.. Nat Commun 14(1):214 PMID: 36639367
- 7. Townsend TA et al.. 2008. Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA.. J Biol Chem 283(20):13834-41 PMID: 18343818
- 8. Singh R et al.. 2012. Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation.. Cell Mol Life Sci 69(8):1377-89 PMID: 22130515
